Evidence map›Paper›PMID 31509321›Full record

ArticleAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2020

Deletion of donor-reactive T cell clones after human liver transplant.

Thomas M Savage, Brittany A Shonts, Saiping Lau, Aleksandar Obradovic, Harlan Robins, Abraham Shaked, Yufeng Shen, Megan Sykes

Open access · bronzeAbstract read
In one paragraph

Article in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 40 citations in OpenAlex.

  1. Selective decrease of donor-reactive TScience translational medicine · 2022
    Trial
  2. Induction of Clinical Operational Tolerance Through Immunosuppression Minimization: Less Is More?Liver international : official journal of the International Association for the Study of the Liver · 2026
    Review
  3. Article
  4. Article
  5. Single-cell transcriptional landscape of liver transplant rejection reveals tissue persistence of clonally expanded, treatment-resistant T cells.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2025
    Article
  6. Review
  7. Article
  8. T-cell receptor sequencing reveals selected donor-reactive CD8American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Strategies for Liver Transplantation Tolerance.International journal of molecular sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Thomas M SavageColumbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, New York, New York.
Brittany A ShontsColumbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, New York, New York.
Saiping LauColumbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, New York, New York.
Aleksandar ObradovicColumbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, New York, New York.
Harlan RobinsFred Hutchinson Cancer Research Center, Adaptive Biotechnologies, Inc., Seattle, Washington.
Abraham ShakedDivision of Transplant Surgery, University of Pennsylvania, Philadelphia, Pennsylvania.
Yufeng ShenDepartments of Systems Biology and Biomedical Informatics, Columbia University, New York, New York.
Megan SykesColumbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, New York, New York.ORCID 0000-0002-4947-4376
Columbia University Irving Medical Center · USColumbia University · USFred Hutch Cancer Center · USUniversity of Pennsylvania · US

Funding

Immune Tolerance Network UM1 2023 SupplementUM1AI109565 · NIAID · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI Mark S Anderson, Jane Hoyt Buckner · 2014 to 2026
$451.6M
Tumor Biology and Microenvironment ProgramP30CA013696 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Parisa Tehranifar · 1985 to 2026
$115.3M
Translational Biomarker Analytical Core (TBAC)P30DK063608 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI DOMENICO ACCILI · 2003 to 2026
$36.7M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007367 · NIGMS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI REINER, STEVEN L · 1985 to 2021
$25.1M
MECHANISMS OF BETA CELL FAILURER01DK064819 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ACCILI, DOMENICO · 2003 to 2025
$10.5M
BD Biosciences InfluxS10OD020056 · OD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SNOECK, HANS-WILLEM E · 2015 to 2015
$600k
TCR and BCR deep sequencing to distinguish autoimmune recurrence from allograft rejectionR21TR002279 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SYKES, MEGAN · 2018 to 2019
$461k
Becton Dickinson LSR II Analytical Flow CytometerS10RR027050 · NCRR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CLYNES, RAPHAEL A. · 2011 to 2011
$413k
NCATS NIH HHS R21 TR002279NCI NIH HHS P30 CA013696NCRR NIH HHS S10 RR027050NIAID NIH HHS UM1 AI109565NIDDK NIH HHS P30 DK063608NIDDK NIH HHS R01 DK064819NIGMS NIH HHS T32 GM007367NIH HHS S10 OD020056The Transplant Forum
6 · The paper itself

Abstract

We recently developed a high throughput T cell receptor β chain (TCRβ) sequencing-based approach to identifying and tracking donor-reactive T cells. To address the role of clonal deletion in liver allograft tolerance, we applied this method in samples from a recent randomized study, ITN030ST, in which immunosuppression withdrawal was attempted within 2 years of liver transplantation. We identified donor-reactive T cell clones via TCRβ sequencing following a pre-transplant mixed lymphocyte reaction and tracked these clones in the circulation following transplantation in 3 tolerant and 5 non-tolerant subjects. All subjects showed a downward trend and significant reductions in donor-reactive TCRβ sequences were detected post-transplant in 6 of 8 subjects, including 2 tolerant and 4 non-tolerant recipients. Reductions in donor-reactive TCRβ sequences were greater than those of all other TCRβ sequences, including 3rd party-reactive sequences, in all 8 subjects, demonstrating an impact of the liver allograft after accounting for repertoire turnover. Although limited by patient number and heterogeneity, our results suggest that partial deletion of donor-reactive T cell clones may be a consequence of liver transplantation and does not correlate with success or failure of early immunosuppression withdrawal. These observations underscore the organ- and/or protocol-specific nature of tolerance mechanisms in humans.

Indexed as

Immunosuppression TherapyClonal DeletionHumansLiver TransplantationTissue DonorsT-LymphocytesTransplantation Tolerancebasic (laboratory) research/scienceimmunobiologyliver transplantation/hepatologymonitoring: immuneT cell biologytolerance

Identifiers

PMID31509321
PMCPMC6984984
OpenAlexW2972569243

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.